In Brief: Beta-carotene study
This article was originally published in The Tan Sheet
Executive Summary
Beta-carotene study: Men with low beta-carotene levels taking beta-carotene supplements (50 mg) every other day show a reduced risk of prostate cancer, according to new findings from the Physicians' Health Study, a trial involving 22,071 U.S. male physicians who were between the ages of 40-84 when the study began in 1982. Physicians with low beta-carotene levels who took supplements were 36% less likely to develop prostate cancer than those with low levels on placebo, Meir Stampfer, MD, et al., Harvard Medical School, reported in an abstract presented May 19 at the annual meeting of the American Society of Clinical Oncology in Denver...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning